Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism

Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism

Objective Patients with drug-induced parkinsonism (DIP) may have nigrostriatal dopaminergic degeneration. We studied the clinical features that may indicate nigrostriatal dopaminergic degeneration in patients with DIP. Methods Forty-one DIP patients were classified into normal and abnormal [18F] FP-...

Full description

Bibliographic Details
Main Authors:	Seung Ha Lee, Han Kyeol Kim, Young Gun Lee, Chul Hyoung Lyoo, Sung Jun Ahn, Myung Sik Lee
Format:	Article
Language:	English
Published:	Korean Movement Disorder Society 2017-01-01
Series:	Journal of Movement Disorders
Subjects:	Drug-induced parkinsonism dopamine transporter positron-emission tomography hyposmia
Online Access:	http://e-jmd.org/upload/jmd-16045.pdf

Similar Items

Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms
by: Chul Hyoung Lyoo, et al.
Published: (2018-01-01)

Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease
by: Silvia Paola Caminiti, et al.
Published: (2017-01-01)

Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson’s Disease
by: Anna Kolacheva, et al.
Published: (2022-12-01)

Apathy and Olfactory Dysfunction in Early Parkinson’s Disease
by: Jin Yong Hong, et al.
Published: (2015-01-01)

Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson’s disease
by: Mao CJ, et al.
Published: (2017-10-01)

Dopamine Synthesis in the Nigrostriatal Dopaminergic System in Patients at Risk of Developing Parkinson’s Disease at the Prodromal Stage
by: Victor Blokhin, et al.
Published: (2024-02-01)

Asymmetric Dopaminergic Degeneration and Attentional Resources in Parkinson’s Disease
by: Paola Ortelli, et al.
Published: (2018-12-01)

Combination of olfactory test and substantia nigra transcranial sonopraphy in the differential diagnosis of Parkinson’s disease: a pilot study from China
by: Chen Wei, et al.
Published: (2012-12-01)

A look back at the prodromal findings in Parkinson’s disease
by: Seyed-Amirabbas Ahadiat, et al.
Published: (2023-11-01)

Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease
by: Frederic Sampedro, et al.
Published: (2019-04-01)

Function and Regulation of ALDH1A1-Positive Nigrostriatal Dopaminergic Neurons in Motor Control and Parkinson’s Disease
by: Kathleen Carmichael, et al.
Published: (2021-05-01)

Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
by: Ingrid Morales, et al.
Published: (2021-11-01)

Emerging Concepts of Motor Reserve in Parkinson’s Disease
by: Seok Jong Chung, et al.
Published: (2020-09-01)

MRI Findings in Parkinson’s Disease: Radiologic Assessment of Nigrostriatal Degeneration
by: Yun Jung Bae, et al.
Published: (2022-05-01)

Comparison between four published definitions of hyposmia in Parkinson's disease
by: Sofia Kanavou, et al.
Published: (2021-08-01)

Clinical and Epidemiological Aspects of Parkinson's Disease in the South of Western Siberia
by: Alexey Sergeevich Rozhdestvensky, et al.
Published: (2020-11-01)

Effect of donepezil for dementia prevention in Parkinson's disease with severe hyposmia (The DASH-PD study): A randomized long-term placebo-controlled trial
by: Toru Baba, et al.
Published: (2022-09-01)

LONG-TERM DOPAMINERGIC THERAPY OF PARKINSON DISEASE
by: O. S. Levin
Published: (2017-05-01)

Parkinson’s disease, dopaminergic drugs and the plant world
by: Peter Kempster, et al.
Published: (2022-09-01)

Differential connectivity of the posterior piriform cortex in Parkinson’s disease and postviral olfactory dysfunction: an fMRI study
by: Charalampos Georgiopoulos, et al.
Published: (2024-03-01)

UPSIT subitems may predict motor progression in Parkinson’s disease
by: Yu-Hsuan Lin, et al.
Published: (2023-10-01)

Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism
by: Timothy J. Collier, et al.
Published: (2007-04-01)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson’s Disease
by: Ioannis Ugo Isaias, et al.
Published: (2016-08-01)

Selective dopaminergic vulnerability in Parkinson’s disease: new insights into the role of DAT
by: Maged M. Harraz, et al.
Published: (2023-08-01)

Association between the Degree of Pre-Synaptic Dopaminergic Pathway Degeneration and Motor Unit Firing Behavior in Parkinson’s Disease Patients
by: Yuichi Nishikawa, et al.
Published: (2021-10-01)

Sexual dysfunction precedes motor defects, dopaminergic neuronal degeneration, and impaired dopamine metabolism: Insights from Drosophila model of Parkinson’s disease
by: Zevelou Koza, et al.
Published: (2023-03-01)

The cross-hemispheric nigrostriatal pathway prevents the expression of levodopa-induced dyskinesias
by: Vishakh Iyer, et al.
Published: (2021-11-01)

Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease
by: Eunju Shin, et al.
Published: (2012-09-01)

Axonal Tract Reconstruction Using a Tissue-Engineered Nigrostriatal Pathway in a Rat Model of Parkinson’s Disease
by: Laura A. Struzyna, et al.
Published: (2022-11-01)

The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
by: Calon Frédéric, et al.
Published: (2011-10-01)

Longitudinal DAT changes measured with [18F]FE-PE2I PET in patients with Parkinson’s disease; a validation study
by: V.S. Kerstens, et al.
Published: (2023-01-01)

Influence of depressive symptoms on dopaminergic treatment of Parkinson’s disease
by: Alexandru eHanganu, et al.
Published: (2014-09-01)

Serial Dopamine Transporter Imaging of Nigrostriatal Function in Parkinson’s Disease With Probable REM Sleep Behavior Disorder
by: Ruihua Cao, et al.
Published: (2020-04-01)

Dopaminergic modulation of emotional conflict in Parkinson’s disease
by: Vanessa eFleury, et al.
Published: (2014-07-01)

Metabolic Covariant Network in relation to Nigrostriatal Degeneration in Carbon Monoxide Intoxication-related Parkinsonism
by: Chiung-Chih eChang, et al.
Published: (2016-05-01)

Neuroinflammation following anti-parkinsonian drugs in early Parkinson’s disease: a longitudinal PET study
by: Tatsuhiro Terada, et al.
Published: (2024-02-01)

Sertraline treatment influences [18F]FE-PE2I PET imaging for Parkinsonism
by: Thomas E. H. Justesen, et al.
Published: (2023-05-01)

Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson’s disease
by: Sandy eStayte, et al.
Published: (2014-08-01)

Advances in non-dopaminergic pharmacological treatments of Parkinson's disease
by: Sandy eStayte, et al.
Published: (2014-05-01)

Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion. A possible compensatory mechanism in Parkinson’s disease
by: Javier eBlesa, et al.
Published: (2011-11-01)